Annals of vascular surgery · 2026
Clinical Practice Guideline for Spontaneous Isolated Superior Mesenteric Artery Dissection (2025 Edition).
СтатьяКлинические рекомендацииОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ling Jin, Sun Jinjian, Hou Yuhang, Wu Mingwei, Yuan Pengfei, Hou Li, Mo Fandi, Zhuang Junli, Yu Xiaohui, Yuan Yan, Li Weixiao, Zhou Wei, Liu Shangyu, Ye Xiaoqiang, Liu Chong, Sun Yingdong, Lian Lishan, Hu Haidi, Duan Chen, Zhang Hong, Ren Mingming, Chen Feng, Cui Mingzhe, Deng Hongping, Wang Lixin, Yuan Ding, Xiong Jiang, Wang Wei, On Behave of Chinese Spontaneous Isolated Superior Mesenteric Artery Dissection Collaboration Group (ISMAD2022).
Аннотация
BACKGROUND: Spontaneous isolated superior mesenteric artery dissection (SISMAD) is a relatively rare but potentially life-threatening disease. Optimal medical management strategies remain uncertain. Therefore, developing evidence-based clinical practice guidelines is essential to improve the treatment of SISMAD.
METHODS: The guideline adopted approaches informed by the Grading of Recommendations, Assessment, Development, and Evaluation methodology and the European Society of Cardiology grading system. Recommendations were formulated according to the quality of evidence, categorized as high (level A), moderate (level B), or low (level C).
RESULTS: After reviewing the literature on eight topics, including clinical presentation, imaging evaluation, classification, medical management strategies, and follow-up, the guideline writing committee issued 19 recommendations based on the currently available evidence.
CONCLUSION: Among the 19 recommendations, only a minority were supported by high-quality evidence, underscoring the urgent need for further well-designed clinical studies and prospective research to refine the management of SISMAD.
METHODS: The guideline adopted approaches informed by the Grading of Recommendations, Assessment, Development, and Evaluation methodology and the European Society of Cardiology grading system. Recommendations were formulated according to the quality of evidence, categorized as high (level A), moderate (level B), or low (level C).
RESULTS: After reviewing the literature on eight topics, including clinical presentation, imaging evaluation, classification, medical management strategies, and follow-up, the guideline writing committee issued 19 recommendations based on the currently available evidence.
CONCLUSION: Among the 19 recommendations, only a minority were supported by high-quality evidence, underscoring the urgent need for further well-designed clinical studies and prospective research to refine the management of SISMAD.